Rapid Micro Biosystems reports impressive revenue growth in 2023, driven by increasing demand for their innovative microbial quality control testing ...
RBC global strategists are optimistic about the market's performance in 2024, favoring sectors like Financials, Materials, Health Care, Energy, and ...
Teva completes enrollment for Phase 3 trial of mdc-TJK, a potential treatment for schizophrenia. Results expected in 2024. #schizophrenia #clinicaltrials
Razer unveils Project Esther, a revolutionary haptic feedback cushion, providing an immersive gaming experience like no other. #RazerProjectEsther #CES2024